The Reeve-Irvine Research Center

What The Reeve-Irvine Research Center does

The Reeve-Irvine Research Center (RIRC) is a nonprofit basic science research center established in 1995 at the University of California, Irvine, dedicated to discovering novel approaches to improve recovery of function after spinal cord injury (SCI). Operating under the UCI Foundation as a 501(c)(3) tax-exempt organization, RIRC employs 6 Resident Principal Investigators and 23 Associate PIs who conduct research on cellular and molecular mechanisms of neural repair, regeneration, and recovery, spanning stem cell therapy, Nogo protein structure, PTEN targeting, AAV viral vector gene delivery, neuroinflammation, and dendrite regeneration. The center's research formed the basis for the world's first two FDA-approved clinical trials testing stem cell therapies in spinal cord injury, and its 2026 Kavli Prize in Neuroscience to founding director Dr. Oswald Steward underscores its scientific standing.

RIRC generates no commercial revenue from products or services; its operating budget is funded through federal research grants (primarily NIH/NINDS), past state funding from the California Institute of Regenerative Medicine, individual donations, and fundraising events such as the annual Thanksgiving Turkey Trot (which has generated approximately $450K). The center's go-to-market motion is event-driven, anchored by the annual Meet the Scientists forum, the Turkey Trot, the Reeve-Irvine Research Medal Award symposium ($50K prize), and a quarterly Spinal Connection News publication that engages the SCI community. Its research outputs flow through peer-reviewed scientific journals, clinical trials, and technology transfer to commercial partners — exemplified by the MusicGlove rehabilitation device licensed to Flint Rehabilitation Devices.

RIRC's stakeholder ecosystem includes SCI patients and the broader spinal cord injury community, scientific collaborators across Harvard, USC, Caltech, Cambridge, and the Long Beach VA SCI/D Center, and funding partners including NIH, CIRM, the W.M. Keck Foundation, and the Joan Irvine Smith & Athalie R. Clarke Foundation. Recent expansions include bidirectional brain-computer interface research with wearable robotic exoskeletons (92% neural decoding, 93% sensory cortex stimulation precision), Alzheimer's neurodegeneration research using PTEN targeting, and clinical balance assessment tools tailored for thoracic SCI.

Name

The Reeve-Irvine Research Center

Legal name

Reeve-Irvine Research Center

Website

https://reeve.uci.edu

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

The Reeve-Irvine Research Center is a nonprofit basic science research center at UC Irvine that studies neural repair, regeneration, and recovery of function after spinal cord injury, funded by NIH grants, state awards, and donations, serving the SCI patient and scientific communities.

Ownership category

akta.pro rank

Product category

Neuroscience Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Neural & Spinal Cord Regeneration (HLAAAGAI)

akta.pro secondary industry

Neurology/CNS Gene Therapies (HLAAACAH)

Keywords

• Spinal cord research
• Neural regeneration therapy
• Stem cell research
• Neuroscience research center
• Rehabilitation technology

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Donations and Charitable Contributions: The center receives donations from individuals to fund early stage proof of concept research. Donations provide critical support for innovative ideas that are too early to qualify for traditional funding sources.
2. Federal Research Grants: Primary funding from National Institutes of Health (NIH), particularly through the National Institute of Neurological Disorders and Stroke (NINDS). Additional funding from W.M. Keck Foundation and FRAXA Research Foundation.
3. State Research Funding: Previously funded by the California Institute of Regenerative Medicine (CIRM). Dr. Steward was a founding member of the ICOC governing board.
4. Event Sponsorships: Sponsorships for events including Meet the Scientists, Turkey Trot, and research projects.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

The Reeve-Irvine Research Center is a basic science research center at the University of California, Irvine, dedicated to studying cellular and molecular mechanisms underlying the nervous system's response to injury and developing treatments for spinal cord injury. Its work spans stem cell therapies, neuronal regeneration, neuroinflammation, bladder function, chronic pain, and rehabilitation technologies, with outputs disseminated through peer-reviewed publications, clinical trials, and training programs. The center is funded through donations, federal grants (NIH/NINDS), state funding, and fundraising events.

Product overview

The Reeve-Irvine Research Center is a basic science research center dedicated to discovering novel approaches to improve recovery of function after spinal cord injury (SCI). The organization operates multiple interconnected research programs centered around three main pillars: Stem Cell Research, Regeneration to Reverse Paralysis, and Other Consequences of SCI including pain and bladder dysfunction. Key research programs include CNS Regeneration, Dendrite Regeneration, Neuroinflammation, and Neurodegeneration in Alzheimer's Disease. The Center also conducts human subjects research including a Clinical Balance Research Study using Microsoft Kinect technology, and develops rehabilitation technologies like the Music Glove. The Roman Reed Spinal Cord Injury Injury Research Program provides seed funding for innovative projects. Educational offerings include postdoctoral training, graduate programs through the Interdepartmental Neuroscience Program, and summer internships. Community engagement features the annual Meet the Scientists Event and the Reeve-Irvine Research Medal Award ($50,000).

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Balance Research Study Active clinical trial developing a new seated balance assessment tool using Microsoft Kinect sensor technology tailored for individuals with thoracic spinal cord injury. Open for participant enrollment.
• Training Programs Educational programs including postdoctoral fellowships, graduate training through the Interdepartmental Neuroscience Program, and summer internships for high school students, designed to train the next generation of spinal cord injury researchers.

Quantifiable outcome

• First two FDA-approved clinical trials for stem cell therapy in spinal cord injury
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Roman Reed Spinal Cord Injury Research ProgramcoreStrategic or Co-development Partner · 1 January 2000Established by the California Legislature through the Roman Reed Spinal Cord Injury Research Act (2000). Named after Don Reed's son Roman who was paralyzed in a high school football game. The program provided seed funding for innovative projects and established a unique laboratory at RIRC dedicated on March 1, 2002. From 2001-2011, $15 million in state funding led to over $80 million in subsequent NIH grants.
• Children's Hospital at Harvard (Dr. Zhigang He)coreStrategic or Co-development PartnerBi-coastal collaboration with Dr. Zhigang He's lab to develop ways to promote regeneration of connections that control voluntary movement. This partnership achieved major breakthroughs showing impressive regeneration on the other side of an injury site.
• Keck School of Medicine of USCcoreStrategic or Co-development PartnerCollaboration on brain-computer interface research with wearable robotic exoskeletons for paraplegia patients. USC leads the $8 million NSF Cyber-Physical Systems grant for developing bidirectional brain-machine interface systems.
• California Institute of Technology (Caltech)coreStrategic or Co-development PartnerCollaboration on brain-computer interface research with wearable robotic exoskeletons. Caltech contributes neuroscience and robotics expertise to the interdisciplinary team.
• University of Cambridge (Dr. Liz Muir and Dr. Elizabeth Bradbury)minorStrategic or Co-development PartnerCollaboration on viral vector research. Dr. Liz Muir provided a version of ChASE that could be expressed by human cells for AAV vector engineering. Dr. Muir and Dr. Bradbury provided technical advice.
• Long Beach VA Medical Center SCI/D CenterminorStrategic or Co-development PartnerCollaboration on clinical research including balance assessment studies and fellowship training programs. Dr. Maya Hatch completed her advanced fellowship at this center.
• iMove LabminorStrategic or Co-development PartnerUCI laboratory co-directed by Dr. Kelli Sharp focusing on rehabilitation technology, motion capture systems, and dance/movement therapy research.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Kentucky Spinal Cord Injury Research Center (KSCIRC): University of Kentucky research center focused on SCI and nervous system repair, with strong federal (NIH) funding and a portfolio of regenerative and rehabilitative research programs. Directly comparable in mission, university affiliation, and SCI-specific basic science orientation.
• Miami Project to Cure Paralysis: University of Miami Miller School of Medicine research center dedicated to spinal cord injury research and cure, including neural regeneration, cell therapy, and rehabilitation. Directly comparable as one of the few US university-affiliated centers singularly focused on SCI basic science and translation.
• McGowan Institute for Regenerative Medicine: University of Pittsburgh institute focused on regenerative medicine and tissue engineering across multiple organ systems including the nervous system. Comparable in scale, NIH-grant-funded basic science focus, and university-based translational research structure.

Broad incumbents

• Craig H. Neilsen Foundation: Major SCI-focused private foundation funding SCI research, rehabilitation, and advocacy. Comparable as a peer funder/convener in the SCI research ecosystem rather than as a research organization itself, with overlapping grantees.
• Christopher & Dana Reeve Foundation: Major national nonprofit funding SCI research, advocacy, and quality-of-life programs. RIRC was named after Christopher Reeve; the Foundation is the most significant sector-wide funder and convener and represents the broader SCI ecosystem RIRC operates in.
• Keck School of Medicine of USC: Active BCI and neurorehabilitation research partner of RIRC, with overlapping programs in brain-machine interfaces and exoskeleton robotics for paralysis. Comparable in university-based SCI/neural engineering translational research.

Others

• International Spinal Cord Society (ISCoS): International scientific and medical society for SCI research, education, and clinical care. Comparable as a global convener and standards-setting body that shapes the research and clinical ecosystem RIRC operates within.

Emerging players

• Lineage Cell Therapeutics: Clinical-stage biotech developing cell transplant therapies for spinal cord injury (OPC1 for acute SCI) and other neurological conditions. Comparable as a translational competitor in SCI cell therapy, downstream of academic research like RIRC's stem cell work.
• Neuralstem (now part of Plurilock): Biotech developing neural stem cell therapies for nervous system diseases including SCI. Comparable as a commercial counterpart translating academic neural regeneration science into clinical-stage programs.

Regional players

• Reeve-Irvine Research Center clinical partners (Long Beach VA SCI/D Center): Federal VA Spinal Cord Injury/Disorders Center serving veterans with SCI and partnering with RIRC on clinical research and fellowships. Comparable as a regional clinical counterpart that operationalizes RIRC's basic science for patient outcomes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/ReeveIrvine
• Facebookfacebook.com/ReeveIrvineResearchCenter
• LinkedInlinkedin.com/company/reeve-irvine-research-center
• Instagraminstagram.com/reeve.irvine

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Reeve-Irvine Research Center